HighField Biopharmaceuticals’ mRNA-based HFG1 Demonstrates Potential as a Longer Acting GLP-1R Agonist for Diabetic Control and Weight Loss
Preclinical results in naturally occurred diabetic monkeys were presented at the American Diabetes Association 84th…